title: Time to review treatment of isoniazid-resistant tuberculosis?
authors.affiliation: WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, IRCCS, Care and Research Institute, Via Roncaccio 16, 21049 Tradate, Italy; Public Health Consulting Group, Lugano, Switzerland.
authors.forename: Lia
authors.initials: L
authors.lastname: D'Ambrosio
authors.affiliation: WHO Collaborating Centre for TB and Lung Diseases, Fondazione S Maugeri, IRCCS, Care and Research Institute, Via Roncaccio 16, 21049 Tradate, Italy; Public Health Consulting Group, Lugano, Switzerland.
authors.forename: Giovanni B
authors.initials: GB
authors.lastname: Migliori
authors.affiliation: Clinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari-Research, Medical Education, and Professional Development Unit, AOU Sassari, Sassari, Italy.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Sotgiu
mesh_terms: D000995:Antitubercular Agents; D006801:Humans; D007538:Isoniazid; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis; D012293:Rifampin; D014376:Tuberculosis; D018088:Tuberculosis, Multidrug-Resistant
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin